GMO Conference | 02 November 2022

GMO 2022 Fall Conference

Now Is Not the Time to Do Nothing

The key investor question today should be where to take risk…not whether to take risk. Solutions exist, and we explored many at GMO’s 2022 Fall Conference.

There has been no shortage of reasons to be nervous this year – market downturns, rising rates, soaring inflation, geopolitical crises, and unprecedented extreme weather, to name just a few. Despite this, investors should not stand still. These very challenges offer opportunity, if looked at from a different perspective.

At our 2022 Fall Conference, over 40 GMO professionals discussed both macro themes and focused investment topics, presenting solutions to the foremost issues facing our clients today.

Explore our topics below and Contact Us or your GMO representative for more information. Intended for accredited investors.

 


The U.S. Superbubble and the End of the Growth Cycle

Featuring Jeremy Grantham discussing the ongoing U.S. superbubble, the state of mean reversion as an investment principle, climate progress and risks, the corrosive nature of inequality, and more

Also featuring Ben Inker updating on the ongoing Value opportunity…and the rise of Deep Value


Inflation, Rates, and Recession Risks

Featuring James Montier explaining why recession is his biggest worry, not persistent inflation


Turbulent Times in Emerging Markets

Featuring Arjun Divecha offering a new, innovative way to invest in emerging markets


Climate Change and Ways to Leverage ESG

Featuring Lucas White assessing the state of the clean energy transition and what that means for climate and natural resource investors


An Altered Fixed Income Landscape

Featuring GMO’s senior fixed income leaders describing how solutions-oriented strategies can help investors use the bond market to their advantage today


Technology Innovation to Generate Alpha

Featuring two ways we are building next-generation technology to help improve our clients’ outcomes – through Natural Language Processing tools and the new Needs-Based Allocation platform for advisors.

Subscribe to GMO Research